Clinical Trials Logo

Filter by:
NCT ID: NCT05497635 Completed - Healthy Subject Clinical Trials

A Study of STSA-1002 in Healthy Subjects

Start date: October 14, 2022
Phase: Phase 1
Study type: Interventional

This study is a Phase Ib, randomized, double-blind, placebo-controlled, multiple dose, dose escalation safety, tolerability,pharmacokinetic and pharmacodynamic study of STSA-1002 injection in healthy subjects. A total of 26 healthy subjects were enrolled in three dosage groups.

NCT ID: NCT05497297 Completed - Renal Impairment Clinical Trials

A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Start date: August 4, 2022
Phase: Phase 1
Study type: Interventional

This is an open-label, single-dose study to evaluate the pharmacokinetics, pharmacodynamics and safety of HSK7653 in subjects with mild, moderate, severe renal impairment and subjects with kidney failure compared to the matched control subjects with normal renal function.

NCT ID: NCT05497258 Completed - Clinical trials for Artificial Intelligence

IDEAS-AAP System Diagnoses Acute Abdominal Pain

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

This is a study to validate the effect of the intelligent diagnostic evidence-based analytic system in acute abdominal pain augmentation. Included physicians were randomly assigned into control or AI-assisted group. In this experiment, the whole electronic health record of each acute abdominal pain patient was divided into two parts, signs and symptoms recording (including chief complaint, present history, physical examination, past medical history, trauma surgery history, personal history, family history, obstetrical history, menstrual history, blood transfusion history, drug allergy history) and auxiliary examination recording (including laboratory examination and radiology report). For each case, the control group readers will first read the signs and symptoms recording of electronic health record and make a clinical diagnosis. Then the readers have to decide to either order a list of auxiliary examinations or confirm the clinical diagnosis without further examination. If the readers choose to order examinations, the corresponding examination results will be feedback to the readers, and the readers can then decide to either continue to order a list of auxiliary examinations or make a confirming diagnosis. Such cycle will last until the reader make a confirming diagnosis. For the AI-assisted readers, the physicians were additionally provided with the feature extracted by IDEAS-AAP, a list of suspicious diagnoses predicted by IDEAS-AAP, and corresponding diagnostic criteria according to guidelines. After the readers get the examination results, the IDEAS-AAP will renew its diagnosis prediction

NCT ID: NCT05496985 Completed - Brain Diseases Clinical Trials

Chinese Validation of the Simplified Evaluation of CONsciousness Disorders(SECONDs)

Start date: December 20, 2021
Phase: N/A
Study type: Interventional

The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .

NCT ID: NCT05496660 Completed - Hamstring Injury Clinical Trials

The Effect of NHE and KT on the Hamstring Strength and Sprint Performance in Collegiate Sprinters

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The invesitgators performed a randomized controlled trial on collegiate sprinters to explore the combined effect of the NHE and KT and randomly allocated the subjects into the experimental (NHE+KT) or control (NHE) group by an independent researcher using the sealed envelopes method. To calculate the sample size, a Cohen's d effect size of 0.4, an alpha level of 0.05, a test power of 0.95 were configured to G*Power software, at least 34 samples were computed. Considering the dropouts, 40 male collegiate sprinters were enrolled, explained the procedures of this study and voluntarily written informed consent. Inclusion criteria was that participants must be male, aged 18 years or older, training at the university level at least 4 times per week, with no history of lower limb injury within the last 6 months and no previous experience of the NHE or KT. Participants who had lower limb mobility limitation or injury especially HSI within 6 months and associated musculoskeletal, respiratory or cardiovascular diseases and was allergic to kinesio tape were excluded.

NCT ID: NCT05496439 Completed - Clinical trials for Heart Failure With Preserved Ejection Fraction

Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction

Start date: March 1, 2020
Phase:
Study type: Observational

Study of the prognosis of patients with heart failure with preserved ejection fraction

NCT ID: NCT05496361 Completed - Clinical trials for Acute Ischemic Stroke

A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke

Start date: January 24, 2021
Phase: N/A
Study type: Interventional

This is a prospective, randomized, single blind, concurrent controlled, multi-center study. Patients presenting with symptoms of acute ischemic stroke who have evidence of a large vessel occlusion in the cerebral circulation.

NCT ID: NCT05496153 Completed - Clinical trials for Cardiovascular Diseases

The Clinical Effect of Adaptive Posture-balance Cardiac Rehabilitation Exercise on Cardiovascular Diseases

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The whole experiment included one-month APBCRE therapy and two assessments. The one-month APBCRE consisted of twelve exercise sessions, evenly three times per week. At baseline and after rehabilitation, participants underwent one assessment, including car-diopulmonary exercise testing (CPET), resting metabolic rate (RMR) detection, and quality of life questionnaire (QoL). The primary outcomes were exercise capacity measured by function parameters at anaerobic threshold (AT) and other CPET physiological indexes. The secondary endpoints were the RMR level and QoL score.

NCT ID: NCT05496075 Completed - Uric Acid Clinical Trials

Orlistat Reduces Uric Acid in Overweight/Obese Patients With Hyperuricemia

Start date: August 26, 2022
Phase: Phase 4
Study type: Interventional

To clarify the uric acid-lowering efficacy of orlistat in overweight/obese patients with hyperuricemia, and to evaluate the safety of orlistat treatment

NCT ID: NCT05493995 Completed - Clinical trials for Pancreatic Neoplasms

A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.

PAAG
Start date: July 21, 2022
Phase: Phase 2
Study type: Interventional

It is a trial to assess the efficacy and safety of Penpulimab and Anlotinib in Combination With Nab-paclitaxel Plus Gemcitabine as first-line Therapy in Patients (Pts) With Metastatic Pancreatic Cancer.